Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

A husband and wife team from Minnesota have opened up about the fateful decision they had to make about their 14-month-old ...

Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...

Right ventricular–pulmonary artery coupling (RV-PAC) describes the energy transfer within the whole cardiopulmonary unit. Thus, it can identify the earliest signs of decompensation even before ...

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

"It hasn't been easy being a mom and dealing with grief ... I struggle with the question of 'How many kids do you have?' " ...

Pulmonary arterial hypertension (PAH) is characterized by significant morbidity and mortality and despite advances, the prognosis remains poor, highlighting the critical need for new therapies and non ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Combination therapy with oral or inhaled treprostinil may benefit patients with pulmonary arterial hypertension and cardiovascular comorbidities.

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...